SLAMF3 expression in HCC retains Retinoblastoma (RB) factor in its hypo-phosphorylated active form, which in turn inactivates E2F transcription factor, thereby repressing the expression and activation of Polo-like kinase Plk-1 (Figure 3). The gene discussed is PLK1; the disease is hepatocellular carcinoma.